To explore the role of androgen receptors in PAH, we administered Enzalutamide via intraperitoneal injection in MCT-induced rats to inhibit androgen receptor expression and used gene editing technology to knock out androgen receptors in C57BL/J6 mice. The gene discussed is AR; the disease is pulmonary arterial hypertension.